J. Keith Joung, PhD

Associate Professor of Pathology, Harvard Medical School

Associate Chief of Pathology for Research

Director, Molecular Pathology Unit, Massachusetts General Hospital

“Targeted Genome Modification Using Engineered Zinc Finger Nucleases”

Share with friends

Added: April 12, 2022

Related News

Air-liquid interface

Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium

Type 2 alveolar epithelial cells (AT2s), facultative progenitor cells of the lung alveolus, play a

Comprehensive phenotyping of hematopoietic stem and progenitor cells in the human fetal liver

Hematopoietic stem cells (HSCs) reside at the top of the hematopoietic hierarchy and can give

Specific mesoderm subset derived from human pluripotent stem cells ameliorates microvascular pathology in type 2 diabetic mice

Human induced pluripotent stem cells (hiPSCs) were differentiated into a specific mesoderm subset characterized by

Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection

There is an urgent need to understand how SARS-CoV-2 infects the airway epithelium and in


Location The Center for Regenerative Medicine 670 Albany St 2nd Floor Boston MA 02118 Boston University & Boston Medical Center

Quick links

Research at the CReM

Cores & Protocols

CReM Labs

Connect

© 2021 CReM. All Rights Reserved.

Positions available Financial Support CReM response to COVID-19

Privacy policy Terms of use